Breaking News, Collaborations & Alliances

Telix, INSERM, and ARRONAX Enter Agreement

To explore the feasibility of using several of Telix's clinical targeting agents with astatine

Telix Pharmaceuticals has entered a research partnership with the French National Institute of Health and Medical Research (INSERM) and the Accelerator for Research in Radiochemistry and Oncology at Nantes Atlantic (ARRONAX).   INSERM is a leading translational research organization with a strong track record of industry engagement and technology development to benefit human health. ARRONAX is a unique cyclotron (particle accelerator) facility and a world-leader in the production of cert...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters